World AIDS Day
1 December 2024
HIV remains one of the most significant global health challenges, particularly in Africa. While great strides have been made since the 1990s, South Africa continues to face the world’s largest HIV epidemic. This World AIDS Day, we shine a light on the ongoing fight against HIV and the efforts of the BRILLIANT Consortium—a USAID-funded Cooperative Agreement aimed at accelerating HIV vaccine discovery in Africa.
The BRILLIANT Consortium represents a unique partnership between African scientists and institutions, driving innovation and strengthening the continent’s leadership in HIV prevention. This collaboration is a significant step forward in the global effort to develop an effective HIV vaccine—a tool that is crucial to ending the epidemic.
In celebration of the Consortium’s efforts, we are sharing key insights from our interviews with some of its leading figures. Here are the perspectives of Professor Glenda Gray, Professor Linda-Gail Bekker, and Dr Nigel Garrett, whose voices exemplify the passion and urgency behind this project.
Breaking New Ground in African Vaccine Development
“This grant is the first of its kind that empowers scientists—and in this case, African scientists—to take a concept from discovery through the preclinical phase into a manufacturing phase and make a clinical batch of an HIV vaccine that we can evaluate in Africa. No network or entity has really ever done that. We are the first group of people that will be able to—from the cradle to the grave—go through a process of putting a vaccine into a human being.” – Professor Glenda Gray, Programme Director and Principal Investigator, BRILLIANT Consortium.
The BRILLIANT Consortium is not just conducting research; it is redefining the vaccine development process by ensuring that African scientists lead and execute projects on the continent.
The Urgency of an HIV Vaccine
“We now still have the biggest epidemic in the world. We still have the largest number of people who need antiretrovirals. We still have almost 2 million people we haven’t found and linked to care. And we still have over 1,000 young women who become infected with HIV every week… We will never be able to stop watching unless we have a vaccine deployed. I feel very strongly that an HIV vaccine is the pinnacle of prevention.” – Professor Linda-Gail Bekker, Co-Principal Investigator; Partner Lead PI, BRILLIANT Consortium.
Professor Bekker’s words highlight the ongoing challenges in the fight against HIV and the critical need for a vaccine as the ultimate preventive measure.
Building on Lessons from COVID-19
“A lot of the senior people in the network come from the COVID response. We have that same energy and drive that we really want to translate into HIV vaccines now. Some of the technology that was used in COVID was actually developed through HIV research. I think HIV deserves to have this attention now and learn from COVID, to close that loop. We feel that we’ve got this huge opportunity now as a team to implement our ideas on the African continent.” – Dr Nigel Garrett, Deputy Program Director (Science); Lead PI; Program Co-Lead: Clinical Program, BRILLIANT Consortium.
Dr Garrett emphasises the Consortium’s ability to leverage the rapid progress made during the COVID-19 pandemic to fast-track HIV vaccine development.
BioInformatiCo’s Role in the Fight Against HIV
BioInformatiCo is proud to contribute to this mission as the Consortium’s appointed clinical data management partner. Over the next few years, our team will provide robust, secure, and validated data management solutions for their clinical trials. By ensuring high-quality clinical data management, we aim to support the development of a safe and effective HIV vaccine—a game-changing tool that could save millions of lives.
Looking Ahead
People talk of the Moonshot, and I feel like we are at this time in HIV vaccine research. The door has been opened, and we are beginning to see the light through the door and what we need to do to move forward. The journey will always be long and hard, but there is no harder vaccine to make. We need the best brains in Africa, and we need the kind of funding support that will achieve this goal of making an HIV vaccine.
– Professor Glenda Gray
This World AIDS Day, we remember the millions of lives lost to HIV, honour those living with the virus, and recommit to supporting the scientists, researchers, and institutions striving to end the epidemic. Together, we can achieve a future free from HIV.
Learn more about the BRILLIANT Consortium here
